BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 26288183)

  • 1. Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.
    Liu Z; Liu J; Li L; Nie D; Tao Q; Wu J; Fan J; Lin C; Zhao S; Ju D
    PLoS One; 2015; 10(8):e0135236. PubMed ID: 26288183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wogonin induces cross-regulation between autophagy and apoptosis via a variety of Akt pathway in human nasopharyngeal carcinoma cells.
    Chow SE; Chen YW; Liang CA; Huang YK; Wang JS
    J Cell Biochem; 2012 Nov; 113(11):3476-85. PubMed ID: 22689083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide Induces Apoptosis and Synergizes with Cisplatin in Cisplatin-Resistant HNE1/DDP Nasopharyngeal Cancer Cells.
    Wang X; Zhang JJ; Sun YM; Zhang J; Wang LR; Li JC; Liu H
    Folia Biol (Praha); 2015; 61(5):195-202. PubMed ID: 26667576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of autophagy inhibitors combined with cisplatin against cisplatin-resistant nasopharyngeal cancer cells.
    Yin W; Xu J; Mao Y
    Biochem Cell Biol; 2021 Jun; 99(3):322-329. PubMed ID: 34038188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of GRP78 enhances cell death by cisplatin and radiotherapy in nasopharyngeal cells.
    Huang YY; Pu LJ; Song LL; Ma LY; Liu H; Jiang CC
    Anticancer Drugs; 2016 Sep; 27(8):726-33. PubMed ID: 27254284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
    Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
    Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
    Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
    Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
    Chen J; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y; Fei Z; Zhu R
    Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium butyrate induces autophagic apoptosis of nasopharyngeal carcinoma cells by inhibiting AKT/mTOR signaling.
    Huang W; Zeng C; Liu J; Yuan L; Liu W; Wang L; Zhu H; Xu Y; Luo Y; Xie D; Jiang X; Ren C
    Biochem Biophys Res Commun; 2019 Jun; 514(1):64-70. PubMed ID: 31023529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction.
    Han Y; Shi D; Li J
    Med Sci Monit; 2019 Nov; 25():8995-9002. PubMed ID: 31770363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells.
    Wang KF; Yang H; Jiang WQ; Li S; Cai YC
    Int J Mol Med; 2015 Dec; 36(6):1556-62. PubMed ID: 26499488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress.
    Li Q; Ni W; Deng Z; Liu M; She L; Xie Q
    Fundam Clin Pharmacol; 2017 Jun; 31(3):301-310. PubMed ID: 28078787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway.
    Li P; Hu J; Shi B; Tie J
    Biochem Biophys Res Commun; 2020 Oct; 531(3):320-327. PubMed ID: 32800561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of cytosine arabinoside and cisplatin enhances inhibition of cell proliferation and promotes apoptosis of resistant nasopharyngeal carcinoma cells].
    Chen J; Liu S; Li Q; Peng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):379-82, 386. PubMed ID: 25744845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.
    Lin FJ; Lin XD; Xu LY; Zhu SQ
    Mol Cells; 2020 Oct; 43(10):856-869. PubMed ID: 33115978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long non-coding RNA XIST modulates cisplatin resistance by altering PDCD4 and Fas-Lexpressions in human nasopharyngeal carcinoma HNE1 cells
    Wang H; Li W; Tan G
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Mar; 39(3):357-363. PubMed ID: 31068307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted antitumor activity of Ginsenoside (Rg1) in paclitaxel-resistant human nasopharyngeal cancer cells are mediated through activation of autophagic cell death, cell apoptosis, endogenous ROS production, S phase cell cycle arrest and inhibition of m-TOR/PI3K/AKT signalling pathway.
    Li W; Li G; She W; Hu X; Wu X
    J BUON; 2019; 24(5):2056-2061. PubMed ID: 31786875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling.
    Chang CH; Lee CY; Lu CC; Tsai FJ; Hsu YM; Tsao JW; Juan YN; Chiu HY; Yang JS; Wang CC
    Int J Oncol; 2017 Mar; 50(3):873-882. PubMed ID: 28197628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.